CLINICAL_TRIALS
trial_result
· 2025-07-30
Clinical Trial Update: A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout [Phase 3]
Summary
A Phase 3 trial evaluating the efficacy of dotinurad and febuxostat in participants with gout has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Co., Ltd. | Conditions: Gout | Phase 3 | Status: COMPLETED | Results posted: 2025-07-30